ERBB2 and breast carcinoma: Knockdown of PSMD3 led to reduced cell proliferation, reduced colony formation, and increased apoptosis in breast cancer cell lines [23], and co-silencing of PSMD3 and HER2 resulted in additive inhibition of cell viability and promoted apoptosis in breast cancer [32].